Dreamgenics participates in a European project funded by the Interreg Sudoe 2021-2027 program.
Cisplatin is a widely used chemotherapeutic agent for the treatment of various types of cancer, however, the use of this drug is associated with some side effects, such as the risk of developing deafness and tinnitus. The monitoring of these adverse effects involves repeated trips by patients to referral centers ... Read More